Patients with asymptomatic or symptomatic HF may be classified as at risk of all-cause death and cardiovascular disease if they have elevated circulating levels of NT-proBNP > 125 pg/mL or >300 pg/mL, respectively [2]. This evidence concerns the gene NPPB and cardiovascular disorder.